Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Apr;13(4):608-12.
doi: 10.1128/AAC.13.4.608.

Antimicrobial susceptibility of Haemophilus ducreyi

Antimicrobial susceptibility of Haemophilus ducreyi

G W Hammond et al. Antimicrob Agents Chemother. 1978 Apr.

Abstract

The susceptibility of 19 isolates of Haemophilus ducreyi from a recent chancroid outbreak and four reference strains was determined in vitro to 13 antimicrobial agents. The rabbit intradermal test for virulence was positive for all of the local isolates, but not for the reference strains. The "nonvirulent" reference strains were inhibited by lower minimum inhibitory concentrations (MICs) of most agents tested. For the virulent isolates, the range of MICs (in micrograms per milliliter) of the following were: of vancomycin, 8 to 128; of polymyxin, 32 to 128; of cloxacillin, 32 to 64; of tetracycline, 0.5 to 32; of cephalothin, 4 to 8; of doxycycline, 0.25 to 8; and of kanamycin, 1 to 8. Three strains were resistant to penicillin and ampicillin (MIC >/= 128 mug/ml), and these three strains produced beta-lactamase. The remainder were susceptible to 4 mug/ml. All strains were susceptible to rifampin (MIC </= 1 mug/ml), chloramphenicol (MIC </= 4 mug/ml), sulfisoxazole (MIC </= 8 mug/ml), and nalidixic acid (MIC </= 8 mug/ml). These susceptibilities of H. ducreyi indicate several antimicrobial agents that may be effective for chancroid treatment and support the use of vancomycin in a selective medium for the culture of chancroid genital ulcers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Invest Dermatol. 1956 May;26(5):415-9 - PubMed
    1. Public Health Rep. 1956 Nov;71(11):1112-4 - PubMed
    1. J Clin Microbiol. 1978 Jan;7(1):39-43 - PubMed
    1. J Gen Microbiol. 1976 Mar;93(1):9-62 - PubMed
    1. Arch Dermatol. 1969 Nov;100(5):604-7 - PubMed

LinkOut - more resources